Despite continuous advances in surgical and immunosuppressive protocols, the long-term survival of transplanted kidneys is still far from being satisfactory. Antibody-mediated rejection, recurrent autoimmune diseases, and death with functioning graft are the most frequent causes of late-kidney allograft failure. However, in addition to these complications, a number of other non-immunologic events may impair the function of transplanted kidneys and directly or indirectly lead to their failure. In this narrative review, we will list and discuss the most important nonimmune causes of late death-censored kidney graft failure, including quality of the donated kidney, adherence to prescriptions, drug toxicities, arterial hypertension, dyslipidemia, new onset diabetes mellitus, hyperuricemia, and lifestyle of the renal transplant recipient. For each of these risk factors, we will report the etiopathogenesis and the potential consequences on graft function, keeping in mind that in many cases, two or more risk factors may negatively interact together.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410103 | PMC |
| http://dx.doi.org/10.3390/jpm12081271 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Apolipoprotein B-48 and late graft failure in kidney transplant recipients.
Clin Kidney J
October 2024
Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Introduction: Transplant vasculopathy resembles atherosclerotic plaque formation and is a major contributor to late graft failure in kidney transplant recipients (KTR). Remnant lipoproteins and associated triglycerides are causal risk factors for atherosclerotic plaques and have been implicated in late kidney graft failure. However, whether remnants derived from liver (containing apolipoprotein [apo] B100) or intestine (containing apoB48) are clinically more important is unclear.
View Article and Find Full Text PDFDefining causes of death-censored kidney allograft failure: A 5-year multicentre ANZDATA and clinical cross-sectional study.
Nephrology (Carlton)
December 2024
Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Article Synopsis
- * Researchers analyzed data from 642 allograft failures, finding that various forms of rejection accounted for the majority (47.5%) of cases, with chronic antibody-mediated rejection being the most common cause.
- * The findings suggest a need for better strategies to manage immune responses and more research on less understood causes of kidney transplant failure, particularly undifferentiated interstitial fibrosis and tubular atrophy.
Early and Late Microvascular Inflammation Have Differing Etiological Causes and Clinical Expression.
Transplantation
September 2024
Department of Tissue Pathology and Diagnostic Oncology, ICPMR, Westmead Hospital, Westmead, NSW, Australia.
Background: Microvascular inflammation (MVI) is an important pathological feature of antibody-mediated rejection (AMR). How posttransplant time affects its clinicopathological expression is little understood.
Methods: This retrospective, single-center study screened 3398 kidney transplant biopsies and dichotomized 202 MVI ≥ 2 (Banff glomerulitis + peritubular capillaritis ≥ 2) samples by 9-mo median incidence time for comparison.
Clinical and molecular spectrum of v-lesion.
Am J Transplant
November 2024
Department of Nephrology, Hospital del Mar, Barcelona, Spain.
Isolated v-lesion presents diagnostic stratification and clinical challenges. We characterized allograft outcomes for this entity based on posttransplant time (early: ≤1 month vs late: >1 month) and compared its molecular phenotype with other v+ rejection forms. Using the NanoString B-HOT panel, we analyzed 92 archival formalin-fixed paraffin-embedded tissue kidney biopsies from 3 centers: isolated v-lesion (n = 23), antibody-mediated rejection (ABMR) v+ (n = 26), T cell-mediated rejection (TCMR) v+ (n = 10), mixed rejection v+ (n = 23), and normal tissue (n = 10).
View Article and Find Full Text PDFOxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes.
Clin Transplant
June 2024
Division of Nephrology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Describing risk factors and outcomes in kidney transplant recipients with oxalate nephropathy (ON) may help elucidate the pathogenesis and guide treatment strategies. We used a large single-center database to identify patients with ON and categorized them into delayed graft function with ON (DGF-ON) and late ON. Incidence density sampling was used to select controls.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!